Patents
Sitemap › A01 - Agriculture; Forestry; Animal husbandry; Hunting; Trapping; Fishing › A01K - Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise provided for; New breeds of animals › A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals
Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2005
12/14/2005EP1434988A4 Transgenic knockouts of bace-1
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005CN2745351Y Timing silkworm feeding device
12/14/2005CN1231117C Industrial breeding technology for seven-star ladybug
12/08/2005WO2005116070A2 Reporter system for detecting signal pathway activation in multiple cell types
12/08/2005WO2005115136A2 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/08/2005WO2005115135A2 Mouse model of crohn’s disease and a method to develop specific therapeutics
12/08/2005WO2005115134A1 Restless legs syndrome/periodic appendicular dyskinesia model animal
12/08/2005WO2005115133A1 Method of gene introduction in in-vivo spermatogenic cell
12/08/2005WO2005089411A3 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
12/08/2005WO2005047469A3 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
12/08/2005WO2004058042A3 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
12/08/2005WO2004047531A3 Protein production in transgenic avians using lentiviral system
12/08/2005US20050273874 Method for producing heart-specific fluorescence of non-human eukaryotic animals
12/08/2005US20050273873 Genomic modification
12/08/2005US20050273872 Protein production in transgenic avians
12/08/2005US20050273871 Method for diagnosing arrhythmogenic right ventricular dysplasia
12/08/2005US20050273870 Preparation and selection of donor cells for nuclear transplantation
12/08/2005US20050273869 Plasmids and phages for homologous recombination and methods of use
12/08/2005US20050273868 Methods and compositions for enhancing RISC activity in vitro and in vivo
12/08/2005US20050273867 Non-invasive real-time in vivo bioluminescence imaging of local Ca²+ dynamics in living organisms
12/08/2005US20050272915 Skrp, astray, string, vacm associated with metabolic control
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272149 Therapeutic delivery of adenosine into a tissue
12/08/2005CA2567429A1 Restless legs syndrome/periodic appendicular dyskinesia model animal
12/08/2005CA2563926A1 Transgenic models of alzheimer's disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/07/2005EP1601965A2 Animal model simulating neurologic disease
12/07/2005EP1601775A1 Animal model for the fast identification of pharmaceutical active compounds in vivo
12/07/2005EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1019491B1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
12/07/2005CN1705744A Transplantable cell
12/07/2005CN1705436A Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny
12/07/2005CN1230541C Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant DNA molecules encoding these enzymes
12/07/2005CN1230539C Bacterial auto-inducer inactivation protein, its coded nucleic acid molecule and uses
12/07/2005CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain
12/07/2005CN1230533C Quiescent cell populations for nuclear transfer
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/01/2005WO2005112622A2 Regulation of transcription with a cis-acting ribozyme
12/01/2005WO2005112621A2 A murine model of hiv-1 infection
12/01/2005WO2005112620A2 A cre-lox based method for conditional rna interference
12/01/2005WO2005112619A2 Novel gene disruptions, compositions and methods relating thereto
12/01/2005WO2005112618A1 Method of making stem cells from differentiated cells
12/01/2005WO2005069975A3 Lysyl oxidase-like 1 (loxl1) and elastogenesis
12/01/2005WO2005050200A3 Screening assays and methods of tumor treatment
12/01/2005US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals
12/01/2005US20050268348 Mouse model for psoriasis and psoriatic arthritis
12/01/2005US20050268347 Transgenic pigs carrying both hHO-1 and hDAF transgenes for xenotransplantation
12/01/2005US20050266561 Use of interfering RNA in the production of transgenic animals
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/01/2005US20050265983 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
12/01/2005CA2567251A1 Multiple transcription unit systemes, vectors and host cells containing them, and methods of making and using them
12/01/2005CA2562482A1 Novel gene disruptions, compositions and methods relating thereto
11/2005
11/30/2005EP1600507A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
11/30/2005EP1599577A2 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response, tamoxifen resistance and metastasis
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy
11/30/2005EP1599231A2 Treatment of pain through expression of opioid receptors
11/30/2005EP1311153B1 High temperature cryogenic preservation of biologically active material
11/30/2005CN1703247A Anti-neovasculature preparations for cancer
11/30/2005CN1229493C Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
11/30/2005CN1229016C Method for industrial cage farming egg ducks
11/29/2005US6969760 Jak kinases and regulation of cytokine signal transduction
11/29/2005US6969597 Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
11/24/2005WO2005111208A1 Method of proliferating plasma cell
11/24/2005WO2005110433A1 Nonhuman animal having expression of bach2 artificially inhibited, and use thereof
11/24/2005WO2005110076A2 Braf expression in zebrafish and uses thereof
11/24/2005WO2005067709A3 Chimeric murine model comprising human hepatocytes user for screening compounds
11/24/2005US20050262580 Transgenic mouse with a targeted deletion of Elovl4 gene
11/24/2005US20050262578 Non-human animal models of atherosclerosis and methods of use thereof
11/24/2005US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
11/24/2005US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
11/24/2005US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/24/2005US20050260746 Transgenic pig containing heat shock protein 70 transgene
11/24/2005US20050260734 Packaging cells
11/24/2005US20050260652 Compositions and methods that modulate RNA interference
11/24/2005US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon
11/24/2005US20050260585 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
11/24/2005US20050260234 Anti-neovasculature preparations for cancer
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260186 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms
11/24/2005US20050260176 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
11/24/2005US20050260163 Triplex hairpin ribozyme
11/24/2005US20050260135 High throughput pharmaceutical screening using drosophila
11/24/2005CA2816163A1 Methods and kits to detect hereditary angioedema type iii
11/24/2005CA2566883A1 Methods and kits to detect hereditary angioedema type iii
11/23/2005EP1597378A2 Production of multimeric proteins
11/23/2005EP0958357B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/23/2005EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/23/2005CN1698426A Low fat chicken raising method
11/22/2005US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005107447A2 Methods for the production of improved live stocks and disease models for therapeutic research
11/17/2005WO2005049063A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005US20050257281 Method for preparing a sterile transgenic fish
11/17/2005US20050257280 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
11/17/2005US20050257279 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 341